tiprankstipranks
pc:ottim

Ottimo Pharma

https://ottimopharma.com/
Ottimo Pharma is a private biotech company focused on developing bifunctional medicines aimed at extending the lives of individuals with cancer. The company is advancing its lead asset, Jankistomig, a first-in-class PD1/VEGFR2 bifunctional antibody designed for multiple solid tumor indications. Ottimo Pharma is also working on a pipeline of follow-on bifunctional assets to further its mission in oncology therapeutics.

Leadership & Board

Current Number of Employees19
Current LinkedIn Followers5,840

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$140M
Total Amount Raised$140M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$140M
Latest Funding Amount$140M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Ottimo Pharma had 19 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
19Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Ottimo Pharma had 5,840 followers as of May 18, 2026. The number of followers increased by 11 (0.19%) week-over-week.
5,840Latest Followers Count
11(0.19%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series A
$140.00M

Investors

Investor Name
Funding Round
Series A
Series A

Related News and Analysis